Once-daily oral elecoglipron produced dose-dependent weight loss in adults with obesity or overweight without diabetes, with ...
Patients with advanced squamous non-small-cell lung cancer who received the bispecific antibody ivonescimab alongside chemotherapy had a 40% lower risk of disease progression or death compared with ...
Policymakers should preserve the achievements of the Transcatheter Aortic Valve Replacement registry while recognizing that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results